How rheumatoid arthritis and Down syndrome are helping researchers find treatments for Alzheimer's
Huntington Potter's clinical trial tests Leukine for reversing Alzheimer's memory loss. Alzheimer's affects 10% of those over 65 and 30-40% of those over 85. Leukine, an FDA-approved drug, showed improvement in a 3-week trial and is now in a 24-week trial. Alzheimer's and Down syndrome share a connection through chromosome 21, influencing Alzheimer's research. Current Alzheimer's drugs slow decline, not reverse it, with side effects like brain bleeding. Behavioral changes like exercise and diet can reduce Alzheimer's risk.
Reference News
Huntington Potter's clinical trial tests Leukine for reversing Alzheimer's memory loss. Alzheimer's affects 10% of those over 65 and 30-40% of those over 85. Leukine, an FDA-approved drug, showed improvement in a 3-week trial and is now in a 24-week trial. Alzheimer's and Down syndrome share a connection through chromosome 21, influencing Alzheimer's research. Current Alzheimer's drugs slow decline, not reverse it, with side effects like brain bleeding. Behavioral changes like exercise and diet can reduce Alzheimer's risk.